M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.52 EUR -3.34% Market Closed
Market Cap: 104.5m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Gross Margin
Maat Pharma SA

67.9%
Current
76%
Average
63.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
67.9%
=
Gross Profit
1.7m
/
Revenue
2.6m

Gross Margin Across Competitors

Country FR
Market Cap 104.7m EUR
Gross Margin
68%
Country FR
Market Cap 6T USD
Gross Margin
0%
Country US
Market Cap 301B USD
Gross Margin
67%
Country US
Market Cap 162B USD
Gross Margin
60%
Country US
Market Cap 127.5B USD
Gross Margin
86%
Country US
Market Cap 115.4B USD
Gross Margin
78%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 138B AUD
Gross Margin
52%
Country US
Market Cap 88.6B USD
Gross Margin
87%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country NL
Market Cap 34.1B EUR
Gross Margin
89%

Profitability Report

View the profitability report to see the full profitability analysis for Maat Pharma SA.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
67.9%
=
Gross Profit
1.7m
/
Revenue
2.6m
What is the Gross Margin of Maat Pharma SA?

Based on Maat Pharma SA's most recent financial statements, the company has Gross Margin of 67.9%.